Beyond Basics: IRDAI’s Regulatory Reach and Product Oversight
Imagine you are an equity analyst evaluating the valuation of a major private-sector life insurance firm. While reviewing the firm’s quarterly filing, you notice a significant shift in their product mix toward complex,...